SUB-TYPE: CLASS 4 CAUTION IN USE
Thornton & Ross have identified that the product labelling for some batches of ‘Pharmacy’ medicines do not contain the ‘P’ symbol, due to a packaging error on the bottle.
MHRA drug alert date: 14 July 2022
MHRA drug alert link:
Pip code | Product Description | Supplier | Batch Numbers |
2469385 | Covonia Night Time Formula 150ml (P) | Thornton & Ross | 00JE 80JG |
322537 | Covonia Original Bronchial Balsam 150ml (P) | Thornton & Ross | 69KE 81KR |
This is a caution in use only we are not accepting stock returns.
Further Information
For medical information or stock control queries please contact : Thornton & Ross on 01484 842217 or thorntonross@medinformation.co.uk
SUB-TYPE: COMPANY-LED RECALL
A.Vogel Ltd is recalling the above batch of Pharmacy only medicine due to a small number of packs that were inadvertently supplied to non-pharmacy retail outlets.
This recall is being issued as a company-led medicines recall as this product is only supplied to several outlets, and the manufacturer has full traceability of the onward distribution by their customers.
Remaining stock of the above batch should be quarantined and returned to the company directly.
MHRA drug alert date: 22 June 2022
MHRA drug alert link:
Pip code | Product | Supplier | Affected Batches |
ALLIANCE DO NOT STOCK | LINOFORCE GRANULES 12 YEARS PLUS | A.VOGEL LTD | 1064615 |
Alliance do not stock this product and therefore we are not accepting stock returns.
For medical information enquiries, please contact:
Gillian Forrest
A..Vogel Ltd
2 Brewster Place
Irvine
Ayrshire
KA11 5DD
Email: gillian@avogel.co.uk
For stock information enquiries, please contact:
Debbie Martin
A.Vogel Ltd
2 Brewster Place
Irvine
Ayrshire
KA11 5DD
Email: debbie@avogel.co.uk
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
SUB-TYPE: COMPANY-LED RECALL
Consilient Health UK Ltd is recalling a specific batch due to limited units from the batch being distributed prior to batch release.
Limited number of units from the batch were distributed prior to batch release. There are no indications of any quality of safety concerns and this recall is precautionary due to the regulatory non-compliance.
This recall is being issued as a company-led medicines recall, as this product is only supplied to several pharmacies and the company has traceability of the onward distribution by their customers.
Remaining stock of the above batch should be quarantined and returned to the company directly.
MHRA drug alert date: 30 May 2022
MHRA drug alert link:
Pip code | Product description | Supplier | Affected Batches |
4039764 | INVITA D3 800 IU CAP (28) | CONSILIENT HEALTH UK LTD | 1389492 |
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
If you have any questions, then please contact your local Service Centre Customer Services team.
SUB-TYPE: CLASS 2 RECALL
Bristol Laboratories Limited are recalling the below batch of product as a precautionary measure due to low dissolution test results reported during ongoing stability studies.
MHRA drug alert date: 13 June 2022
Pip code | Product Description | Supplier | Batch Numbers |
ALLIANCE DO NOT STOCK | PHENOBARBITAL 60MG TABLETS | BRISTOL LABORATORIES LIMITED | NW0001 |
Alliance do not stock the above product so we will not be accepting Customer returns on this recall.
Further Information
For more information, medical or supply enquiries, please contact notifications@bristol-labs.co.uk
Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice.
SUB-TYPE: CLASS 2 RECALL
Hameln pharma ltd are recalling batches of product additional to the batch recalled on 15 February 2022 (reference EL(22)A/06). This recall is conducted as a precautionary measure, as remaining vials may no longer be in line with the licensed product specification with respect to the parameters pH and conductivity.
MHRA drug alert date: 25 May 2022
Pip code | Product description | Supplier | Batch Numbers |
0769489 | WATER FOR INJ BP VIAL R/C 100ML (25) | HAMELN PHARMACEUTICALS LTD (MOV) | 019501 019502 019503 019504 019505 019506 920503 920506 920508 930503 930504 930505 931501 940501 940502 951504 952501 |
Further Information
For more information, medical or supply enquiries, please contact: drug.safety@hameln-pharma.co.uk
For stock control queries, please contact: customer.services@hameln-pharma.co.uk
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification by the 26 August 2022, cannot be reimbursed by way of a credit
SUB-TYPE: CLASS 2 RECALL
Quadrant Pharmaceuticals Ltd are recalling a specific batch of Mefenamic Acid 500mg Film-Coated, 30 Tablets as a precautionary measure, due to observations of a defective layer of film coating in some tablets, resulting in the tablet core being partially exposed.
MHRA drug alert link:
Pip code | Product Description | Supplier | Batch Numbers |
ALLIANCE DO NOT STOCK | MEFENAMIC ACID 500MG FILM COATED, 30 TABLETS | QUADRANT PHARMACEUTICALS LTD | 107082 |
Alliance do not stock the above product so we will not be accepting Customer returns on this recall.
Further Information
For more information, medical or supply enquiries, please contact joanne.fishwick@maxearn.co.uk or radoslaw.bandomir@maxearn.co.uk
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
SUB-TYPE: CLASS 4 CAUTION IN USE
GlaxoSmithKline UK Ltd have informed the MHRA that an incorrect version of the Summary of Product Characteristics section 4.2 and the Patient Information Leaflet is inside the sealed pack, and contains unapproved text.
MHRA drug alert link:
Pip code | Product description | Supplier | Batch Numbers |
489633 | ZOVIRAX IV VIAL 500MG | GLAXOSMITHKLINE UK LTD | 9G4B TC8E-A 6V8W GN8S J69C B35J |
This is a caution in use only we are not accepting stock returns.
Further Information
If you have any questions, please contact GSK UK Ltd Medical Information Department on 0800 221 441 or email: ukmedinfo@gsk.com
SUB-TYPE: CLASS 2 RECALL
Pfizer Limited are recalling all batches of Accupro 5mg, 10mg, 20mg, 40mg film-coated tablets as a precautionary measure.
MHRA drug alert link:
Pip code | Product description | Supplier | Batch Numbers |
258764 | ACCUPRO TAB 5MG X 28 | PFIZER LTD | FJ7218 EY5501 EA9306 |
258780 | ACCUPRO TAB 10MG X 28 | PFIZER LTD | FK8588 EP6753 |
258822 | ACCUPRO TAB 20MG X 28 | PFIZER LTD | FF8046 FF8045 EA9304 DK4190 |
2035467 | ACCUPRO TAB 40MG X 28 | PFIZER LTD | FK9758 EP1602 CW7390 |
Further Information
For medical information enquiries, please contact Pfizer Medical Information Department on 01304 616161.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 2 RECALL
Fresenius Kabi Limited are recalling the below batch of product as a precautionary measure due to the identification of particles in the solution for infusion, following routine batch analysis and subsequent batches manufactured on the same filling line. The company’s investigation indicates that he particles appear to originate from the interaction between the equipment and the packaging material during the filling process. The integrity of the packaging and sterility of the product are not compromised.
MHRA drug alert link:
Pip code | Product description | Supplier | Batch Number |
ALLIANCE DO NOT STOCK | SODIUM BICARBONATE 1.26% SOLUTION FOR INFUSION 500ML | FRESENIUS KABI LIMITED | 22BC01 |
Further Information
For more information, medical or supply enquiries, please contact 01928 533 758 FK.Complaints-UK@fresenius-Kabi.com or Customer.Services-UK@Fresenius-Kabi.com
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
SUB-TYPE: CLASS 2 RECALL
Crescent Pharma Limited are recalling the below batch of product as a precautionary measure due to out of specification results for dissolution during routine stability testing.
MHRA drug alert link:
Pip code | Product description | Supplier | Batch Numbers |
8150096 | PAROXETINE TAB 40MG X 30 | CRESCENT PHARMA LTD | 06309 |
Further Information
For more information, medical or supply enquiries, please contact 01256 772730
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.